Cargando…
Interleukin-3-Receptor-α in Triple-Negative Breast Cancer (TNBC): An Additional Novel Biomarker of TNBC Aggressiveness and a Therapeutic Target
SIMPLE SUMMARY: Molecular and histological profiling is crucial for biomarker and therapeutic target discovery, for example, in TNBC. We demonstrated that IL-3Rα expression led to the identification of a subgroup of TNBC patients displaying a poor overall survival. Moreover, we refined TNBC molecula...
Autores principales: | Koni, Malvina, Castellano, Isabella, Venturelli, Emilio, Sarcinella, Alessandro, Lopatina, Tatiana, Grange, Cristina, Cedrino, Massimo, Femminò, Saveria, Cossu-Rocca, Paolo, Orrù, Sandra, D’Ascenzo, Fabrizio, Cotellessa, Ilaria, Tampieri, Cristian, Debernardi, Carla, Cugliari, Giovanni, Matullo, Giuseppe, Camussi, Giovanni, De Miglio, Maria Rosaria, Brizzi, Maria Felice |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9406043/ https://www.ncbi.nlm.nih.gov/pubmed/36010912 http://dx.doi.org/10.3390/cancers14163918 |
Ejemplares similares
-
Targeting IL-3Rα on tumor-derived endothelial cells blunts metastatic spread of triple-negative breast cancer via extracellular vesicle reprogramming
por: Lopatina, Tatiana, et al.
Publicado: (2020) -
Correction: Targeting IL-3Rα on tumor-derived endothelial cells blunts metastatic spread of triple-negative breast cancer via extracellular vesicle reprogramming
por: Lopatina, Tatiana, et al.
Publicado: (2023) -
Extracellular Vesicles: Emergent and Multiple Sources in Wound Healing Treatment
por: Sarcinella, Alessandro, et al.
Publicado: (2023) -
Chemotherapy with ceramide in TNBC
por: Legembre, Patrick, et al.
Publicado: (2015) -
GHRH-antagonists in TNBC
por: Engel, Jörg B.
Publicado: (2015)